Sino Biopharm nets €750m from debut CB
Sino Biopharmaceutical issued a zero coupon convertible bond on Wednesday, boosting the size to €750m as demand poured in from across Asia, Europe and the US, according to multiple sources close to the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: